• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Heather Danks Named Chief Technology Officer at LEX Diagnostics

    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech

    South Korean Regulators Authorize Expanded NeuroStar TMS Indications

    Ian T. Meredith Joins Avertix Medical’s Board

    Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.

    Johari Digital Healthcare Ltd.

    Providence Enterprise USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.

    Johari Digital Healthcare Ltd.

    Providence Enterprise USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Study: PROPEL Sinus Implant is More Effective Treatment Than Non Drug-Eluting Spacers

    The device also saves money, as it helps reduce post-operative complications.

    Business Wire08.14.20
    Intersect ENT Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, has announced the results of a United Kingdom-based independent analysis measuring costs and patient outcomes of the PROPEL steroid releasing sinus implant compared to a non-drug-eluting spacer following endoscopic sinus surgery for patients with chronic sinusitis. The study demonstrated that the use of PROPEL following surgery resulted in fewer post-operative complications and could save the National Health System (NHS) approximately £160,692 over a six-month time horizon.
     
    The study, conducted by Device Access U.K., showed that use of PROPEL following sinus surgery is a more effective intervention (than non-drug-eluting spacers) causing fewer occurrences of symptom recurrence or surgical failure when compared to spacers alone. Through localized, gradual delivery of mometasone furoate over 30 days, PROPEL maintained patency and provided drug delivery without the need for patient interaction, minimizing reliance on patient compliance. While the cost of initial treatment with PROPEL was greater, a reduction in the number of post-operative complications resulted in an overall cost savings.
     
    Chronic rhinosinusitis is one of the most common chronic health problems among adults in the United Kingdom resulting in approximately 75,000 annual physician visits.1 Of those with chronic rhinosinusitis, approximately 15 percent undergo sinus surgery yearly after failing medical treatment.2 Quality of life scores of patients with chronic rhinosinusitis are significantly lower than in other common chronic diseases, such as congestive heart failure, angina, chronic obstructive pulmonary disease, and back pain.3 Chronic rhinosinusitis symptoms may include drainage of excess mucus, nasal blockage or congestion, difficulty breathing, pain and tenderness around the eyes, cheeks, nose and forehead, a reduced sense of smell and taste, and fatigue and irritability.4
     
    “The data analysis provides promising insight into the potential cost savings and improved patient outcomes associated with the use of the PROPEL drug eluting sinus implant following endoscopic sinus surgery,” said study author Dr. Mehdi Javanbakht, head of Health Economics Unit at Device Access U.K. Ltd., University of Southampton Science Park. “Post-operative treatment regimens are critical to surgery success, but current options fall short in minimizing post-operative complications. PROPEL offers patients with chronic rhinosinusitis a safe and effective option that reduces the likelihood of unpleasant complications, thereby decreasing the need for post-operative interventions.”
     
    The PROPEL family of drug-eluting stents expand to prop open the sinuses after sinus surgery and gradually deliver mometasone furoate, an anti-inflammatory medicine, directly to the sinus lining before dissolving. PROPEL and PROPEL Mini received CE Mark in July 2014.
     
    “More than 350,000 patients have been treated with PROPEL products globally, demonstrating acceptance among patients, their physicians and payors in the United States,” said Thomas A. West, president and CEO at Intersect ENT. “We are pleased that this independent analysis adds to the robust clinical data supporting the effectiveness of the PROPEL family of sinus implants as well as highlighting the potential economic and quality of life benefits associated with PROPEL products.”

    References 
    1 Philpott C, Hopkins C, Erskine S, Kumar N, Robertson A, Far- boud A, et al. The burden of revision sinonasal surgery in the UK—data from the chronic rhinosinusitis epidemiology Study (CRES): a cross-sectional study. BMJ Open. 2015;5(4):e006680.
    2 https://link.springer.com/article/10.1007/s41669-020-00198-8
    3 Metson RB, Gliklich RE. Clinical outcomes in patients with chronic sinusitis. Laryngoscope. 2000;110(3 Pt 3):24–8.
    4 Mayo Clinic. Chronic Sinusitis Symptoms and Causes
    Related Searches
    • multipoint pacing technology
    • lbt innovations
    • mark tryniski
    • dr. ervin braun
    Suggested For You
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RonovoRx RonovoRx's RenovoCath Earns New FDA 510(k)
    FDA OKs SpinTech FDA OKs SpinTech's STAGE MRI Software
    BioFourmis BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status
    Nevro Corp Receives FDA Approval for Senza System Nevro Corp Receives FDA Approval for Senza System
    FDA Approves AtriCure FDA Approves AtriCure's EPi-Sense System for Persistent Afib
    Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Trial Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Trial
    Neuronetics Appoints Robert Cascella to its Board of Directors Neuronetics Appoints Robert Cascella to its Board of Directors
    J&J Vision ACUVUE Abiliti Overnight Lenses for Myopia Earn FDA Approval J&J Vision ACUVUE Abiliti Overnight Lenses for Myopia Earn FDA Approval
    FDA Grants Breakthrough Device Status to Epilepsy Treatment System FDA Grants Breakthrough Device Status to Epilepsy Treatment System
    Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure
    Hillrom Advances Its Physical Assessment Tools Hillrom Advances Its Physical Assessment Tools
    LivaNova, Verily Begin Difficult-to-Treat Depression Study LivaNova, Verily Begin Difficult-to-Treat Depression Study
    Solid Growth Forecast for Australian Implantable Ports Market  Solid Growth Forecast for Australian Implantable Ports Market

    Related Breaking News

    • Cardiovascular
      FDA Approves Abbott

      FDA Approves Abbott's Portico with FlexNav TAVR System

      Self-expanding TAVR valve features intra-annular (within the native valve) leaflets.
      PR Newswire 09.20.21

    • Vertigo Treatment Receives FDA Breakthrough Device Designation

      Vertigo Treatment Receives FDA Breakthrough Device Designation

      The device's developer—Otolith Labs—closes $3.3 million in seed financing.
      Business Wire 09.13.21

    • Surgical
      RonovoRx

      RonovoRx's RenovoCath Earns New FDA 510(k)

      Use of RenovoCath may improve targeted delivery of chemotherapy.
      PR Newswire 09.07.21


    • Neurological | Software & IT
      FDA OKs SpinTech

      FDA OKs SpinTech's STAGE MRI Software

      Allows scanning the entire brain in roughly five minutes.
      PR Newswire 08.09.21

    • Cardiovascular | Digital Health
      BioFourmis

      BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status

      Augments guideline-directed use of heart failure medications.
      PR Newswire 07.30.21

    Loading, Please Wait..

    Trending
    • RJG Names Winners Of 2023 RJG Mold Smart Award
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • A New Approach To Post-Market Surveillance
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • Heather Danks Named Chief Technology Officer at LEX Diagnostics
    • Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    • South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    • Ian T. Meredith Joins Avertix Medical’s Board
    • Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Curcumin May Be As Effective as PPI for Indigestion
    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies
    Coatings World

    Latest Breaking News From Coatings World

    WEG Among the Best Companies in Brazil in 2023
    EMPA Develops Flame Resistant Epoxy Resin
    Becker’s Global Mental Health Program Shows Positive Impact
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Heather Danks Named Chief Technology Officer at LEX Diagnostics
    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Nexcella Completes 2nd NXC-201 Engineering Batch
    Almirall Upgrades Werum PAS-X MES
    Rentschler Names Industry Veterans to Leadership Posts
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    IT Award Winners Announced at MakeUp in NY
    GK Hair Expands Color Range to 125 Hues
    WPO and AIPIA Sign MoU to Collaborate on Smart Packaging
    Happi

    Latest Breaking News From Happi

    Augustinus Bader Introduces Body Cleanser
    Daniel C. Liebler Wins 2023 RIFM Board of Directors Excellence in Science Award
    NAD Refers SBLA Beauty To Federal Trade Commission
    Ink World

    Latest Breaking News From Ink World

    HYBRID Software’s PrintFusion for Koenig & Bauer
    Fujifilm Announced European Release of the Acuity Prime Hybrid
    Pacific Coatings Show Invites Industry to Top-Class Programs
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Appvion introduces pre-siliconized Résiste SR
    Vibrant Labelexpo Europe 2023 concludes in Brussels
    Kenco Label & Tag adds sheeting system from Daco Solutions
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Ahlstrom Launches Nonwoven Laundry Care Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Tyber Nets Several Regulatory Nods for K-Wires, Steinmann Pins
    Relievant Medsystems Releases Medability-Powered Intracept Simulator
    AOFAS, Arthritis Foundation Award Grants to Fuel Ankle Arthritis Research
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    ASSA ABLOY Acquires Forte in Peru
    Le Biscuit Boosts Omnichannel Operations with Zebra Technologies
    German Government, Bavaria Commit Support to ams OSRAM

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login